merged_progeria-dna-base-editing.txt
<question_number>1</question_number>
<answer>Nicole Gaudelli</answer>
<other>The article states Gaudelli "produced one anyway with a survival-of-the-fittest experiment."</other>
<question_number>2</question_number>
<answer>N/A</answer>
<other>The article states the goal is to start the trial in two years or less, but does not mention FDA approval timeline assuming success.</other>